Treatment of autoimmune and inflammatory disease

Details for Australian Patent Application No. 2009279471 (hide)

Owner Glaxo Group Limited

Inventors Leung, Stuart; Li, Lixin; Liu, Xeubin; Lu, Hongtao; Tsui, Ping; Zang, Jingwu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009279471

PCT Pub. Number WO2010/017468

Priority 61/087,294 08.08.08 US; 61/169,801 16.04.09 US; 61/218,627 19.06.09 US

Filing date 7 August 2009

Wipo publication date 11 February 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/017468 Priority application(s): WO2010/017468

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279473-C7-fluoro substituted tetracycline compounds

2009279464-Gene methylation in cancer diagnosis